Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.
Legend Biotech Corporation - American Depositary Shares (LEGN)
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
LEGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEGN alerts
High impacting Legend Biotech Corporation - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
LEGN
News
- US lawmakers ask FBI for briefing on GenScript Biotech's links to China [Yahoo! Finance]Yahoo! Finance
- Legend Biotech to Participate in the Jefferies Global Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Legend Biotech to Participate in the Jefferies Global Healthcare ConferenceBusiness Wire
- Legend Biotech Co. (NASDAQ: LEGN) had its price target lowered by analysts at HC Wainwright from $86.00 to $73.00. They now have a "buy" rating on the stock.MarketBeat
- Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA [Yahoo! Finance]Yahoo! Finance
LEGN
Earnings
- 5/13/24 - Beat
LEGN
Sec Filings
- 5/23/24 - Form 6-K
- 5/13/24 - Form 6-K
- 4/22/24 - Form 6-K
- LEGN's page on the SEC website